Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB)
Glucagon-Like Peptide-1 (GLP-1) is an insulin secretagogue which is elevated after Roux-en-Y Gastric Bypass (RYGB). However, its contribution to glucose metabolism after RYGB remains uncertain.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Meera Shah, Marcello C. Laurenti, Chiara Dalla Man, Jing Ma, Claudio Cobelli, Robert A. Rizza, Adrian Vella Source Type: research
More News: Biomedical Science | Diabetes | Diabetes Type 2 | Endocrinology | Gastric Bypass | Gastroenterology | Insulin